[A fatal case of a hepatitis B virus carrier with fulminant hepatic failure after cytotoxic chemotherapy for malignant lymphoma].
A 48-year-old woman with malignant lymphoma, who was diagnosed as a hepatitis B virus (HBV) carrier because of positive HBs antigen, was admitted to Chiba Cancer Center Hospital. Complete remission was achieved by two courses of combination chemotherapy, but fulminant hepatitis developed after withdrawal of chemotherapy and she died of hepatic failure. Retrospective analysis of viral DNA disclosed a mutation in the precore region of HBV-DNA in her serum. We consider that the precoremutant virus was associated with the pathogenesis of severe hepatic failure after withdrawal of cytotoxic chemotherapy.
Kumagai
K
K
Division of Hematology-Chemotherapy, Chiba Cancer Center Hospital.
Takagi
T
T
Sakai
C
C
Oguro
M
M
Kawai
S
S
Nakahori
S
S
Yokosuka
O
O
Ohtoh
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002353:Carrier State / Q000382:microbiology; D017809:Fatal Outcome; D005260:Female; D006501:Hepatic Encephalopathy / Q000139:chemically induced*; D006509:Hepatitis B / Q000150:complications* / Q000382:microbiology; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009154:Mutation